NATURAL-KILLER CELL-DEPENDENT MYCOBACTERIOSTATIC AND MYCOBACTERIOCIDAL ACTIVITY IN HUMAN MACROPHAGES

被引:0
|
作者
BERMUDEZ, LEM
YOUNG, LS
机构
来源
JOURNAL OF IMMUNOLOGY | 1991年 / 146卷 / 01期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Host defense mechanisms against Mycobacterium avium complex (MAC) are poorly understood. Recent evidence suggests the role of NK cells in the host defense against some intracellular pathogens. We investigated whether Nk cells play a role in MAC infection. IL-2-activated human NK cells were incubated with human monocyte-derived macrophages either before or after infection with MAC. Macrophages were lysed 3 and 5 days after infection for quantitation of viable intracellular organisms. Although no killing was observed by nonstimulated macrophages, exposure to IL-2-treated NK cells for 24 h before infection induced macrophage to kill 70 +/- 8% of intracellular MAC by 3 days, and 81% +/- 4% in 5 days (p < 0.01 for both compared with control). Killing was not blocked by incubation with anti-TNF antibody (Ab) or anti-IFN-gamma Ab. Similarly, incubation of macrophages for 24 h with supernatant obtained from IL-2 activated NK cells was associated with 74 +/- 4% killing of intracellular MAC in 3 days and 81 +/- 6% in 5 days (p < 0.01 for both compared with control). However, the supernatant-mediated activation was partially blocked by anti-TNF Ab (46 +/- 6%; p < 0.05) but not by anti-IFN-gamma Ab. When infected macrophages were incubated with NK cells 24 h after infection for 48 h, they killed 54 +/- 3% of intracellular M. avium in 3 days and 73 +/- 5% in 5 days (p < 0.02 for both compared with control). This effect was also not blocked by either anti-TNF or anti-IFN-gamma Ab. These results suggest that activated NK cells may have an important role in the intracellular killing of MAC and that the NK-mediated activation of macrophages is in part mediated by TNF.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 50 条
  • [21] EFFECTS OF LEVAMISOLE ON HUMAN NATURAL-KILLER AND KILLER CELL-ACTIVITY AND PRODUCTION OF INTERFERONS
    LIBERATI, M
    BORDEN, EC
    MCBAIN, JA
    RAUBERTAS, R
    IMMUNOPHARMACOLOGY, 1982, 5 (01): : 11 - 18
  • [22] EVALUATION OF NATURAL-KILLER ACTIVITY IN HUMAN SCHISTOSOMIASIS
    BARSOUM, IS
    FREEMAN, GL
    HABIB, M
    ELALAMY, MA
    ROCHA, RS
    KATZ, N
    GAZZINELLI, G
    COLLEY, DG
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (03): : 451 - 454
  • [23] ANTIBACTERIAL ACTIVITY OF HUMAN NATURAL-KILLER CELLS
    GARCIAPENARRUBIA, P
    KOSTER, FT
    KELLEY, RO
    MCDOWELL, TD
    BANKHURST, AD
    JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01): : 99 - 113
  • [24] NATURAL-KILLER ACTIVITY IN HUMAN CYCLIC NEUTROPENIA
    HARA, T
    ISHII, E
    UEDA, K
    MIZUKOSHI, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (03) : 630 - 632
  • [25] CELLS WITH NATURAL-KILLER ACTIVITY IN HUMAN RABIES
    PANPANICH, T
    HEMACHUDHA, T
    PIYASIRISILP, S
    MANATSATHIT, S
    WILDE, H
    PHANUPHAK, P
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1992, 89 (03): : 414 - 418
  • [26] HUMAN SEMINAL PLASMA SUPPRESSION OF NATURAL-KILLER CELL-ACTIVITY
    TARTER, TH
    KOIDE, SS
    CUNNINGHAMRUNDLES, S
    CLINICAL RESEARCH, 1984, 32 (02): : A385 - A385
  • [27] GENERAL ANESTHETIC AGENTS AND HUMAN NATURAL-KILLER CELL-ACTIVITY
    GRIFFITHS, D
    ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (01) : 99 - 99
  • [28] HYDROXYL RADICALS PARTICIPATE IN HUMAN NATURAL-KILLER CELL-ACTIVITY
    SUTHANTHIRAN, M
    SOLOMON, SD
    RUBIN, AL
    NOVOGRODSKY, A
    STENZEL, KH
    CLINICAL RESEARCH, 1982, 30 (02): : A358 - A358
  • [29] CIMETIDINE AND NATURAL-KILLER CELL-ACTIVITY
    CALVIERI, S
    GIANNELLI, V
    ZAMPETTI, M
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1988, 13 (04) : 283 - 283
  • [30] AUGMENTATION OF HUMAN NATURAL-KILLER CELL-ACTIVITY BY CYCLOPHOSPHAMIDE INVITRO
    SHARMA, B
    VAZIRI, ND
    CANCER RESEARCH, 1984, 44 (08) : 3258 - 3261